Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study"
- 1 March 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Clinical Drug Investigation
- Vol. 40 (3), 287-288
- https://doi.org/10.1007/s40261-020-00889-4
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort StudyClinical Drug Investigation, 2019
- Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesityJournal of Thrombosis and Thrombolysis, 2019
- Individualized Dosing of Enoxaparin for Subjects With Renal Impairment Is Superior to Conventional Dosing at Achieving Therapeutic ConcentrationsTherapeutic Drug Monitoring, 2010
- Antithrombotic Therapy in ChildrenSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- Dose-Ranging Trial of Enoxaparin for Unstable Angina: Results of TIMI 11AJournal of the American College of Cardiology, 1997
- Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators.1997